Chikashi Yoshida

National Hospital Organization Mito Medical Center — Japan

Medicine · Health Sciences

19h-index1.1kcitations90works1.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(41), Chronic Lymphocytic Leukemia Research(39), Eosinophilic Disorders and Syndromes(21), Lymphoma Diagnosis and Treatment(17), Acute Myeloid Leukemia Research(11)

Publications90 total

Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan
International Journal of Hematology·2026Open Access
Five-year interim analysis of multi-institutional collaborative study for estimating the persistence of treatment free remission in chronic myeloid leukemia after stopping tyrosine kinase inhibitor in Japan: J-SKI
Blood·2025
Distinct follicular T cell subsets regulate lymphoma progression and outcomes
Cancer Cell·2025· 3 citedOpen Access
Thoracoabdominal Normothermic Regional Perfusion: Real-world Experience and Outcomes of DCD Liver Transplantation
Transplantation Direct·2025· 9 citedOpen Access
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study
Annals of Hematology·2025· 4 citedOpen Access
Should EAD Be Redefined in the Modern Era of DCD Liver Transplantation?
American Journal of Transplantation·2025Open Access
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02
International Journal of Hematology·2024
Spatially Resolved Single-Cell Transcriptomics of T Cells in Follicular Lymphoma Reveals Distinct Immune Ecosystems
Blood·2024Open Access
Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
Cancer·2024· 2 citedOpen Access
Asciminib: the next-generation bullet for first-line treatment of chronic myeloid leukemia
Med·2024· 1 citedOpen Access
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard‐dose azacitidine
Cancer Reports·2023Open Access
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor <i>BCR-ABL</i> (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Japanese Journal of Clinical Oncology·2023· 2 citedOpen Access
The Outcomes of Pregnancies in Japanese Patients with CML in the TKI Era; A Result of Nationwide Survey
Blood·2023Open Access
Practical and Flexible Genome Profiling Study Using the Halo-Shape Annealing and Defer-Ligation Enrichment (HANDLE) System: HM-Screen-JAPAN02
Blood·2023
Distinct Minor Neoplastic Follicular T-Cell Subsets Dictate Lymphoma Fates through Functional Specialization
Blood·2023
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan
Japanese Journal of Clinical Oncology·2023· 6 citedOpen Access
Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study
International Journal of Hematology·2023· 7 citedOpen Access
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy
International Journal of Hematology·2022· 4 cited
A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling
Nature Cell Biology·2022· 97 citedOpen Access
[Acute myeloid leukemia harboring NUP98::DDX10].
PubMed·2022
page 1 of 5Next →

Frequent Co-authors

Takashi Kumagai(20), Koiti Inokuchi(19), Hisashi Sakamaki(16), Junichi Sakamoto(14), Hisashi Wakita(13), Naoki Takezako(12), Hiroshi Kojima(12), Atsushi Shinagawa(12), Satoshi Morita(11), Kazuteru Ohashi(9), Yasuji Kouzai(9), Shinichiro Okamoto(9), Takuya Komeno(9), Toshiro Nagasawa(8), Shin Fujisawa(8), Shingo Yano(8), Harumi Y. Mukai(8), Shigeru Chiba(7), Kaichi Nishiwaki(7), Noriyoshi Iriyama(7)